Veeva and Zifo Partner to Accelerate Quality Control Modernization
Veeva Systems (NYSE: VEEV) and Zifo announced a product partnership aimed at modernizing quality control operations in biopharma. The integration combines Veeva LIMS with Zifo's data integration platform, qcKen, enabling direct data import from any source document or other LIMS systems.
The partnership will simplify master data configuration during LIMS implementation and site deployment, helping companies transition from legacy QC systems. The collaboration focuses on streamlining test and specification data creation, expediting implementation processes, and delivering faster ROI for new Veeva LIMS customers.
As part of the agreement, Zifo becomes an official Veeva Product Partner, expanding their existing relationship as a Veeva Services Partner. The integration aims to support GMP quality business processes with greater accuracy while helping organizations increase scale and speed batch release cycles.
Veeva Systems (NYSE: VEEV) e Zifo hanno annunciato una partnership per un prodotto che ha come obiettivo la modernizzazione delle operazioni di controllo qualità nel settore biopharma. L'integrazione combina Veeva LIMS con la piattaforma di integrazione dati di Zifo, qcKen, consentendo l'importazione diretta dei dati da qualsiasi documento sorgente o altri sistemi LIMS.
La partnership semplificherà la configurazione dei dati principali durante l'implementazione del LIMS e il dispiegamento sul sito, aiutando le aziende a passare da sistemi QC legacy. La collaborazione si concentra sull'ottimizzazione della creazione di dati di test e specifiche, accelerando i processi di implementazione e offrendo un ritorno sull'investimento più rapido per i nuovi clienti di Veeva LIMS.
Come parte dell'accordo, Zifo diventa un partner ufficiale di prodotto di Veeva, ampliando la loro relazione esistente come partner di servizi di Veeva. L'integrazione mira a supportare i processi aziendali di qualità GMP con maggiore precisione, aiutando le organizzazioni ad aumentare la scala e la velocità dei cicli di rilascio dei lotti.
Veeva Systems (NYSE: VEEV) y Zifo anunciaron una asociación de producto con el objetivo de modernizar las operaciones de control de calidad en biopharma. La integración combina Veeva LIMS con la plataforma de integración de datos de Zifo, qcKen, permitiendo la importación directa de datos desde cualquier documento fuente u otros sistemas LIMS.
La asociación simplificará la configuración de datos maestros durante la implementación de LIMS y el despliegue en el sitio, ayudando a las empresas a transición de sistemas de control de calidad heredados. La colaboración se centra en optimizar la creación de datos de pruebas y especificaciones, acelerando los procesos de implementación y proporcionando un retorno de la inversión más rápido para los nuevos clientes de Veeva LIMS.
Como parte del acuerdo, Zifo se convierte en un socio oficial de producto de Veeva, ampliando su relación existente como socio de servicios de Veeva. La integración tiene como objetivo apoyar los procesos de calidad GMP con mayor precisión, mientras ayuda a las organizaciones a aumentar la escala y la velocidad de los ciclos de liberación de lotes.
Veeva Systems (NYSE: VEEV)와 Zifo는 생명공학 분야의 품질 관리 작업 현대화를 목표로 한 제품 파트너십을 발표했습니다. 이 통합은 Veeva LIMS와 Zifo의 데이터 통합 플랫폼인 qcKen을 결합하여 모든 원본 문서나 다른 LIMS 시스템에서 직접 데이터를 가져올 수 있도록 합니다.
파트너십은 LIMS 구현 및 사이트 배포 중 마스터 데이터 구성을 간소화하여 기업이 구식 QC 시스템에서 전환하는 데 도움을 줄 것입니다. 이 협력은 테스트 및 사양 데이터 생성을 효율화하고 구현 프로세스를 가속화하며 새로운 Veeva LIMS 고객을 위한 더 빠른 투자 수익을 제공합니다.
합의의 일환으로 Zifo는 Veeva 제품의 공식 파트너가 되어 Veeva 서비스 파트너로서의 기존 관계를 확장합니다. 이 통합은 더 높은 정확도로 GMP 품질 비즈니스 프로세스를 지원하는 것을 목표로 하며, 조직이 배치 릴리스 주기를 확대하고 속도를 높이는 것을 도와줍니다.
Veeva Systems (NYSE: VEEV) et Zifo ont annoncé un partenariat produit visant à moderniser les opérations de contrôle qualité dans le secteur biopharma. L'intégration combine Veeva LIMS avec la plateforme d'intégration de données de Zifo, qcKen, permettant une importation directe des données à partir de tout document source ou d'autres systèmes LIMS.
Ce partenariat simplifiera la configuration des données maîtresses lors de l'implémentation de LIMS et du déploiement sur site, aidant les entreprises à passer de systèmes QC obsolètes. La collaboration se concentre sur l'optimisation de la création des données de test et de spécification, en accélérant les processus de mise en œuvre et en offrant un retour sur investissement plus rapide pour les nouveaux clients de Veeva LIMS.
Dans le cadre de l'accord, Zifo devient un partenaire de produit officiel de Veeva, élargissant sa relation existante en tant que partenaire de services Veeva. L'intégration vise à soutenir les processus métier de qualité GMP avec une plus grande précision tout en aidant les organisations à augmenter l'échelle et la vitesse des cycles de libération des lots.
Veeva Systems (NYSE: VEEV) und Zifo haben eine Produktpartnerschaft angekündigt, die darauf abzielt, die Qualitätssicherungsoperationen im Biopharma-Sektor zu modernisieren. Die Integration kombiniert Veeva LIMS mit Zifos Datenintegrationsplattform qcKen, die einen direkten Datenimport aus任何 Quelldokument oder anderen LIMS-Systemen ermöglicht.
Die Partnerschaft wird die Konfiguration von Stammdaten während der LIMS-Implementierung und der Standortbereitstellung vereinfachen und Unternehmen helfen, von veralteten QC-Systemen zu wechseln. Die Zusammenarbeit konzentriert sich darauf, die Erstellung von Test- und Spezifikationsdaten zu optimieren, Implementierungsprozesse zu beschleunigen und eine schnellere Kapitalrendite für neue Veeva LIMS-Kunden zu liefern.
Im Rahmen der Vereinbarung wird Zifo ein offizieller Veeva-Produktpartner und erweitert damit ihre bestehende Beziehung als Veeva-Servicepartner. Die Integration zielt darauf ab, die GMP-Qualitätsgeschäftsprozesse mit höherer Genauigkeit zu unterstützen und gleichzeitig den Organisationen zu helfen, die Skalierung und Geschwindigkeit der Batchfreigabezyklen zu erhöhen.
- Strategic partnership enhances Veeva's LIMS offering with data integration capabilities
- Potential for faster customer implementation and ROI generation
- Expansion of existing partnership indicates strong business relationship
- None.
Insights
This partnership, while appearing routine on the surface, carries strategic significance for Veeva's competitive positioning in the life sciences software market. The integration addresses a critical pain point in LIMS implementation - the complex and time-consuming process of master data configuration and migration from legacy systems. This has historically been a major barrier to adoption of new LIMS solutions.
From a market perspective, this collaboration strengthens Veeva's position against competitors like LabWare and Thermo Fisher Scientific. By simplifying the implementation process, Veeva can potentially:
- Lower the total cost of ownership for customers
- Reduce implementation timelines, accelerating revenue recognition
- Decrease customer hesitation in switching from legacy systems
However, investors should note that while this partnership enhances Veeva's product offering, it's unlikely to materially impact near-term financial results. LIMS implementations typically represent a small portion of Veeva's
The partnership also signals Veeva's continued execution of its platform strategy, building an ecosystem of integrated solutions that increase switching costs and enhance competitive moats. This approach has historically driven Veeva's impressive
Integration will reduce the burden of master lab data configuration, lowering costs and speeding Veeva LIMS implementation
"We are excited to partner with Veeva to offer powerful solutions to the life sciences industry," said Kannan Jagamoorthy, general manager and head of Zifo North America. "Our collaboration will help customers expedite their adoption of Veeva LIMS to streamline operations."
With Veeva, companies take a holistic approach to quality assurance (QA) and QC to support GMP quality business processes with greater accuracy. Using Zifo's qcKen will help accelerate test and specification data creation, streamline implementation and site deployments, and deliver a faster return on investment for new Veeva LIMS customers.
"Veeva LIMS is designed specifically for life sciences organizations looking to advance their QC operations, increase scale, and speed batch release cycles," said Ashley McMillan, senior director, Veeva LIMS strategy. "Partnering with Zifo allows customers to implement Veeva LIMS and realize value much quicker, accelerating QC modernization initiatives."
As part of the partnership, Zifo is an official Veeva Product Partner, building on its existing relationship as a Veeva Services Partner. Watch this to learn how a unified cloud LIMS can improve right first time and accelerate batch release.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
About Zifo
Zifo is the leading global enabler of AI and data-driven enterprise informatics for science-driven organizations. With extensive solutions and services expertise spanning research, development, manufacturing, and clinical domains, we serve various industries, including pharma, biotech, chemicals, food and beverage, oil and gas, and FMCG. Trusted by over 190 science-focused organizations worldwide, Zifo is the partner of choice for advancing digital scientific innovation. For more information, visit zifornd.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at sec.gov.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-and-zifo-partner-to-accelerate-quality-control-modernization-302358419.html
SOURCE Veeva Systems
FAQ
What is the purpose of the Veeva Systems (VEEV) and Zifo partnership announced in January 2024?
How will the Veeva LIMS and Zifo integration benefit biopharma companies?
What is Zifo's new role in the partnership with Veeva Systems (VEEV)?
How does the Veeva-Zifo partnership affect LIMS implementation time and ROI?
